Toronto, Ontario–(Newsfile Corp. – March 8, 2022) – West Island Brands Inc. (CSE: WIB) (FSE: 39N0) (OTCQB: WIBFF) (“West Island” or the “Company”) is pleased to announce the Company’s subsidiary, RoyalMax Biotechnology Canada Inc. D.B.A. West Island Culture (“West Island”), has completed and submitted the required materials to amend the Company’s Health Canada license to enable the sale of cannabis extracts, including hashish, as per Cannabis 2.0. Once amended, West Island will be authorized upon receipt to process and sell Cannabis 2.0 products directly to provincial distributors and other authorized Canadian retail supply channels.
Further, West Island Culture has entered an agreement to market cannabis-based hashish and other concentrates with Oaziz Extracts Inc. (“Oaziz”). Oaziz is Montreal-based, Health Canada Licence Holder which specializes in the development, processing, and production of cannabis-based concentrates. West Island and Oaziz will cooperate to develop, produce, and commercialize strain specific cannabis extracts in Canada for sale through West Island’s distribution network.
Oaziz CEO, Jorge Sousa, “The Oaziz’s team his excited to be working with the WIB management team, this might be news to many today however it has been over a year that both teams have been exchanging and exploring ideas. Based on the principle of this agreement our focus will be to delight consumers in specific cannabis product segments.”
About West Island
West Island is a multi-faceted, innovative company in the Quebec cannabis space. Its subsidiary, RoyalMax Biotechnology Canada Inc. is a Dorval, Quebec based Health Canada Licence Holder with standard cultivation licence, standard processing, medical sales, and sales licences. The Company continues to work with Yunify Natural Technologies, a Quebec based health and personal care research and innovation company to develop proprietary products for West Island including topicals and ionic mists. Through its acquisition of Trichome Treats, an award-winning chocolatier, the Company intends on introducing edibles into the West Island product mix.
Oaziz Extracts “raison d’être ” is to provide the necessary resources to our partners for the development of cannabis extract products while respecting the environment and our communities. Our aim is to be a trusted custodian of cannabis refinement.
For more information on West Island Brands please visit the website at: westislandbrands.com.
For more information on Oaziz please visit the website at: oaziz.ca.
On behalf of the Board of Directors
WEST ISLAND BRANDS INC.
Boris Ziger, CEO & Chairman
Disclaimer for Forward-Looking Information
Certain information in this press release may constitute forward-looking information. This information is based on current expectations that are subject to significant risks and uncertainties that are difficult to predict. Actual results might differ materially from results suggested in any forward-looking statements. The Corporation assumes no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those reflected in the forward-looking statements unless and until required by securities laws applicable to the Corporation. Additional information identifying risks and uncertainties is contained in the Corporation’s filings with the Canadian securities regulators, which filings are available at www.sedar.com.
Neither the Canadian Securities Exchange nor its Market Regulator (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release. We seek Safe Harbor.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/115894